| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Mar―21 |
In-silico design of peptide inhibitors targeting the SARS-CoV-2 spike protein using mutagenesis-based remodelling |
Farhan Ullah, Abdus Samad, Shahid Ullah, Peter Chinedu Agu, Na Yang, Ming Lei, Liang Chen, Sheng Wang |
| 2 |
[GO] |
2026―Feb―25 |
Structure-guided screening of bioactive phytoconstituents as prospective inhibitors of SARS-CoV-2 Mpro |
Sarika Bano, Taj Mohammad, Jyotishna Singh, Arunabh Choudhury, Asimul Islam, Md. Imtaiyaz Hassan, Sanjay Kumar Dey |
| 3 |
[GO] |
2024―Apr―26 |
Targeting COVID-19 (SARS-CoV-2) main protease through phytochemicals of Albizia lebbeck: molecular docking, molecular dynamics simulation, MM-PBSA free energy calculations, and DFT analysis |
Nasiruddin Nalban, Manish Wanjari, Rasika Kolhe, Munaf Tamboli, Pallavi Jamadagni |
| 4 |
[GO] |
2024―Jan―08 |
Publisher Correction: An in silico investigation of the phytomolecules present in Piper longum roots as a potential treatment for SARS-CoV-2 |
Indrajeet Singh, Juveriya Israr, Ajay Kumar |
| 5 |
[GO] |
2023―Dec―15 |
Molecular docking and molecular dynamics studies of anti-allergic medicines as inhibitors against COVID-19 |
Mrinal Kanti Si, Manoj R. Patle, Shraddha Pandey |
| 6 |
[GO] |
2023―Nov―16 |
An in silico investigation of the phytomolecules present in Piper longum roots as a potential treatment for SARS-CoV-2 |
Ajay Kumar |
| 7 |
[GO] |
2023―Apr―13 |
Evolutionary aspects of mutation in functional motif and post-translational modifications in SARS-CoV-2 3CLpro (Mpro): an in-silico study |
Amit Gupta, Niharika Sahu, Vinay Kumar Singh, Rajeshwar P. Sinha |
| 8 |
[GO] |
2021―Sep―15 |
Therapeutically effective covalent spike protein inhibitors in treatment of SARS-CoV-2 |
Vikram Choudhary, Amisha Gupta, Rajesh Sharma, Hamendra Singh Parmar |
| 9 |
[GO] |
2021―Aug―25 |
In silico molecular docking of SARS-CoV-2 surface proteins with microbial non-ribosomal peptides: identification of potential drugs |
Poonam Bansal, Raman Kumar, Jasbir Singh, Suman Dhanda |
| 10 |
[GO] |
2021―Jun―09 |
Screening of FDA-approved compound library identifies potential small-molecule inhibitors of SARS-CoV-2 non-structural proteins NSP1, NSP4, NSP6 and NSP13: molecular modeling and molecular dynamics studies |
Shobana Sundar, Lokesh Thangamani, Shanmughavel Piramanayagam, Chandrasekar Narayanan Rahul, Natarajan Aiswarya, Kanagaraj Sekar, Jeyakumar Natarajan |
| 11 |
[GO] |
2021―Apr―09 |
The percentages of SARS-CoV-2 protein similarity and identity with SARS-CoV and BatCoV RaTG13 proteins can be used as indicators of virus origin |
Mohammed Elimam Ahamed Mohammed |
| 12 |
[GO] |
2021―Mar―23 |
Structure-based inhibitor screening of natural products against NSP15 of SARS-CoV-2 revealed thymopentin and oleuropein as potent inhibitors |
Ramachandran Vijayan, Samudrala Gourinath |
| 13 |
[GO] |
2021―Feb―14 |
Aggregation hot spots in the SARS-CoV-2 proteome may constitute potential therapeutic targets for the suppression of the viral replication and multiplication |
Shalini Gour, Jay Kant Yadav |
| 14 |
[GO] |
2021―Jan―20 |
Comments on potential re-purposing of medicines against high-altitude illnesses towards SARS-CoV2: possibilities and pitfalls |
Yasmin Ahmad, Subhojit Paul, Rajeev Varshney, Bhuvnesh Kumar |
| 15 |
[GO] |
2020―Aug―31 |
A rapid and sensitive method to detect SARS-CoV-2 virus using targeted-mass spectrometry |
Praveen Singh, Rahul Chakraborty, Robin Marwal, V. S. Radhakrishan, Akash Kumar Bhaskar, Himanshu Vashisht, Mahesh S. Dhar, Shalini Pradhan, Gyan Ranjan, Mohamed Imran, Anurag Raj, Uma Sharma, Priyanka Singh, Hemlata Lall, Meena Dutta, Parth Garg, Arjun Ray, Debasis Dash, Sridhar Sivasubbu, Hema Gogia, Preeti Madan, Sandhya Kabra, Sujeet K. Singh, Anurag Agrawal, Partha Rakshit, Pramod Kumar, Shantanu Sengupta |
| 16 |
[GO] |
2020―May―31 |
Virtualization of science education: a lesson from the COVID-19 pandemic |
Sandipan Ray, Sanjeeva Srivastava |
